期刊文献+

水飞蓟素对大鼠缺血再灌注损伤的保护作用 被引量:4

Protective effects of Silymarin on ischemia-reperfusion injury in rats
下载PDF
导出
摘要 目的 探讨水飞蓟素对大鼠缺血再灌注损伤的保护作用。方法  2 0只大鼠随机分为对照组和观察组 ,各 10只 ,两组术前分别灌服 0 .5 %羧甲基纤维素钠 (CMCNa)溶液和水飞蓟素CMCNa混悬液 ,观察组大鼠腹主动脉缺血 30 m in后再灌注 4 5 m in,检测并比较两组血清中丙二醛 (MDA )及超氧化物歧化酶 (SOD)的变化。结果 两组缺血前血清中 MDA含量及 SOD活性无显著差异 (P>0 .0 5 )。再灌 4 5 min后 ,两组 MDA含量均有升高 ,但观察组明显低于对照组 (P<0 .0 1) ;再灌 4 5 m in后 ,血清中 SOD均有所下降 ,但观察组下降幅度明显低于对照组 (P<0 .0 1)。结论 水飞蓟素对缺血再灌注损伤具有保护作用。 Objective To investigate the protective effects of Silymarin on ischemia-reperfusion injury in rats. Methods Sprague Dawley(SD) rats were randomly divided into 2 groups including one control group(n=10) and the observation group(n=10) . The two groups were separately given 0.5% carboxymethylcellulose Na(CMCNa)solution and CMCNa suspension of silymarin , then the observation group was treated with 30 min ischemia followed by 45 min reperfusion. Serum levels of malondialdehyde(MDA)and superoxide dismutase(SOD) after being treated with Silymarin were detected and compared.Results The MDA and SOD were not obviously different in both serum before ischemia(P>0.05),but after 45 min reperfusion , MDA content significantly increased and the observation group was obviously lower than the control one (P<0.01),while SOD activities declined and the observation group was obviously higer than the control one (P<0.01). Conclusion Silymarin can protect tissue against ischemia-reperfusion injury.
出处 《新乡医学院学报》 CAS 2004年第3期177-178,共2页 Journal of Xinxiang Medical University
关键词 水飞蓟素 缺血再灌注 丙二醛 超氧化物歧化酶 Silymarin ischemia-reperfusion injury malondialdehyde superoxide dismutase
  • 相关文献

参考文献7

二级参考文献24

共引文献111

同被引文献47

  • 1李萍,熊凡,富青,杨莉,姚小卫,袁艇.参麦注射液对抗大鼠心肌缺血再灌注性心律失常作用[J].中国医院药学杂志,2005,25(9):815-817. 被引量:22
  • 2赵宗江,刘昆,张新雪,牛建昭.异病同治和同病异治理论在多器官纤维化防治中的应用[J].中医杂志,2005,46(10):727-729. 被引量:19
  • 3Tapmeier T T, Brown K L,Tang Z,et al. Reimplantation of the u- reter after unilateral ureteral obstruction provides a model that al- lows functional evaluation [ J ]. Kidney lnt, 2008,73 ( 7 ) : 885- 889. 被引量:1
  • 4Jeong D H, Lee G P, Jeong W I, et al. Alterations of mast cells and TGF-betal on the silymarin treatment for CCI4-induced he- patic fibrosis [ J]. World J Gastroenterol, 2005,11 ( 8 ) : 1141- 1148. 被引量:1
  • 5Singh R P, Deep G, Chittezhath M,et al. Effect of silibinin on the growth and progression of primary lung tumors in mice[ J]. J Natl Cancer lnst,2006,98 ( 12 ) :846-855. 被引量:1
  • 6Song Z,Deaciuc I,Song M,et al. Silymarin protects against acute ethanol-induced hepatotoxicity in mice[ J]. Alcohol Clin Exp Res, 2006,30( 3 ) :407-413. 被引量:1
  • 7Sobolova L, Skottova N, Vecera R,et al. Effect of silymarin and its polyphenolic fraction on cholesterol absorption in rats [ J ]. Phar- macol Res,2006,53 (2) :104-112. 被引量:1
  • 8Zeisberg M, Neilson E G. Mechanisms of tubulointerstitial fibrosis [ J]. J Am Soc Nephrol,2010,21 ( 11 ) : 1819-1834. 被引量:1
  • 9Crocenzi F A, Roma M G. Silymarin as a new hepatoprotective a- gent in experimental cholestasis: new possibilities for an ancient medication [ J ]. Curr Med Chem,2006,13 ( 9 ) : 1055-1074. 被引量:1
  • 10Chevalier R L, Forbes M S, Thomhill B A. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy [ J ]. Kidney Int,2009,75(11 ) :1145-1152. 被引量:1

引证文献4

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部